For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.
Treatment Study for Patients with Complex Regional Pain Syndrome
The purpose of this study is to study an investigational drug, neridronic acid, to test its safety in subjects with complex regional pain syndrome.
In order to participate you must meet the following criteria:
- Have CRPS.
You will be excluded from the study if any of the following criteria apply to you:
- Have renal disease.
- Have denture related gum trauma.
This is a partial list of inclusion and exclusion criteria.